177 related articles for article (PubMed ID: 33620909)
1. Vaginal Estrogen as First-Line Therapy for Recurrent Urinary Tract Infections in Postmenopausal Women and Risk Factors for Needing Additional Therapy.
Chang E; Kent L; Prieto I; Eggers E; Tanner JP; Bassaly R; Wyman A; Greene K
Female Pelvic Med Reconstr Surg; 2021 Mar; 27(3):e487-e492. PubMed ID: 33620909
[TBL] [Abstract][Full Text] [Related]
2. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials.
Chen YY; Su TH; Lau HH
Int Urogynecol J; 2021 Jan; 32(1):17-25. PubMed ID: 32564121
[TBL] [Abstract][Full Text] [Related]
3. Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial.
Ferrante KL; Wasenda EJ; Jung CE; Adams-Piper ER; Lukacz ES
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):112-117. PubMed ID: 31232721
[TBL] [Abstract][Full Text] [Related]
4. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
[TBL] [Abstract][Full Text] [Related]
5. Estrogen therapy in older patients with recurrent urinary tract infections: a review.
Rozenberg S; Pastijn A; Gevers R; Murillo D
Int J Fertil Womens Med; 2004; 49(2):71-4. PubMed ID: 15188831
[TBL] [Abstract][Full Text] [Related]
6. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.
Perrotta C; Aznar M; Mejia R; Albert X; Ng CW
Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women.
Tan-Kim J; Shah NM; Do D; Menefee SA
Am J Obstet Gynecol; 2023 Aug; 229(2):143.e1-143.e9. PubMed ID: 37178856
[TBL] [Abstract][Full Text] [Related]
8. The role of estrogens in female lower urinary tract dysfunction.
Robinson D; Cardozo LD
Urology; 2003 Oct; 62(4 Suppl 1):45-51. PubMed ID: 14550837
[TBL] [Abstract][Full Text] [Related]
9. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women.
Long CY; Liu CM; Hsu SC; Chen YH; Wu CH; Tsai EM
Fertil Steril; 2006 Jan; 85(1):155-60. PubMed ID: 16412747
[TBL] [Abstract][Full Text] [Related]
10. Should hormone replacement therapy (any route of administration) be considered in all postmenopausal women with lower urinary tract symptoms? Report from the ICI-RS 2023.
Taithongchai A; Mohamed-Ahmed R; Sinha S; Gibson W; Giarenis I; Robinson D; Abrams P
Neurourol Urodyn; 2024 Aug; 43(6):1321-1327. PubMed ID: 38289324
[TBL] [Abstract][Full Text] [Related]
11. Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
Jackson SL; Scholes D; Boyko EJ; Abraham L; Fihn SD
Obstet Gynecol; 2006 Oct; 108(4):855-62. PubMed ID: 17012446
[TBL] [Abstract][Full Text] [Related]
12. Vaginal Estrogen Therapy Is Associated With Decreased Inflammatory Response in Postmenopausal Women With Recurrent Urinary Tract Infections.
Meister MR; Wang C; Lowder JL; Mysorekar IU
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e39-e44. PubMed ID: 31725016
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
[TBL] [Abstract][Full Text] [Related]
14. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.
Eriksen B
Am J Obstet Gynecol; 1999 May; 180(5):1072-9. PubMed ID: 10329858
[TBL] [Abstract][Full Text] [Related]
15. The detection and management of vaginal atrophy.
Johnston SL; Farrell SA; Bouchard C; Farrell SA; Beckerson LA; Comeau M; Johnston SL; Lefebvre G; Papaioannou A;
J Obstet Gynaecol Can; 2004 May; 26(5):503-15. PubMed ID: 15151738
[TBL] [Abstract][Full Text] [Related]
16. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
[TBL] [Abstract][Full Text] [Related]
17. [Local estrogen therapy--clinical implications--2012 update].
Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
[TBL] [Abstract][Full Text] [Related]
18. [Prevention and treatment of recurrent urinary system infection with estrogen cream in postmenopausal women].
Xu R; Wu Y; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2001 Sep; 36(9):531-3. PubMed ID: 11769665
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee.
Cardozo L; Lose G; McClish D; Versi E; de Koning Gans H
Int Urogynecol J Pelvic Floor Dysfunct; 2001; 12(1):15-20. PubMed ID: 11294525
[TBL] [Abstract][Full Text] [Related]
20. The effect of local estrogen therapy on the urinary microbiome composition of postmenopausal women with and without recurrent urinary tract infections.
Anglim B; Phillips C; Shynlova O; Alarab M
Int Urogynecol J; 2022 Aug; 33(8):2107-2117. PubMed ID: 34003309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
